Acute Lung Injury Market-Global Opportunity Analysis and Industry Forecast, 2017-2023
Acute Lung Injury Market by Therapy (Pharmacotherapy, Mechanical Ventilation, Adjunctive Procedures, Fluid Management, and Others) and End User (Hospitals, Clinics, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023
- Report Number: 2005
- Publish Date: 20-May-2018
Acute lung injury is a life-threatening condition caused by severe acute hypoxemic respiratory failure. It is a key source of mortality and morbidity in critically ill patients without any evidence of hydrostatic pulmonary edema. Symptoms observed in acute lung injury include severe shortness of breath, low blood pressure, confusion, and extreme tiredness. This type of injury has a substantial impact on public health, with a high incidence across the world and it requires administration of a fast and goal-oriented therapy to suppress further lung damage.
The major factor that drives the acute lung injury market is rise in prevalence of lung-related diseases, increase in geriatric population, growth in awareness about daily health diagnostics, and technological advancements. However, high cost of therapies, and low adoption rate of digital radiography and portable spirometers for diagnosing the condition impede the market growth. Furthermore, advancements in surgical techniques and the perioperative management, and development of new treatment strategies to improve outcomes are expected to provide numerous opportunities for market expansion in the near future.
The global acute lung injury market is segmented based on therapy, end user, and region. Based on therapy, it is categorized into pharmacotherapy, mechanical ventilation, adjunctive procedures, fluid management, and others. Based on end user, it is segmented into hospitals, clinics, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in this market include Altor BioScience Corporation, FirstString Research, Inc., GlaxoSmithKline Plc, Forschung und Entwicklung GmbH, Commence Bio, Inc., CompleGen, Inc., Histocell S.L., Stemedica Cell Technologies, Inc., Windtree Therapeutics, Inc., and S-Evans Biosciences, Inc.
- The study provides an in-depth analysis of the global acute lung injury market with current trends and future estimations from 2016 to 2023 to elucidate the imminent investment pockets.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
- Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
Acute Lung Injury Market Key Segments:
- Mechanical Ventilation
- Adjunctive Procedures
- Fluid Management
By End User
- North America
- Rest of Europe
- Rest of Asia-Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA
Table Of Content
Chapter: 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.4.1. Secondary research
Chapter: 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
Chapter: 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2.1. Top investment pockets
3.3. MARKET SHARE ANALYSIS, 2016
Chapter: 4 ACUTE LUNG INJURY MARKET, BY THERAPY
4.1.1. Market size and forecast
4.2.1. Key market trends
4.3. MECHANICAL VENTILATION
4.3.1. Key market trends
4.4. ADJUNCTIVE PROCEDURES
4.4.1. Key market trends
4.5. FLUID MANAGEMENT
4.5.1. Key market trends
4.6.1. Key market trends
Chapter: 5 ACUTE LUNG INJURY MARKET, BY END USER
5.1.1. Market size and forecast
5.2.1. Market size and forecast
5.3.1. Market size and forecast
5.4.1. Market size and forecast
Chapter: 6 ACUTE LUNG INJURY MARKET, BY REGION
6.2.1. Key market trends
22.214.171.124. U.S. market size and forecast
6.2.4. North America Acute Lung Injury Market by Therapy
6.3.1. Key market trends
126.96.36.199. Germany market size and forecast
6.3.4. Europe Acute Lung Injury Market by Therapy
6.4.1. Key market trends
188.8.131.52. Japan market size and forecast
6.4.4. Asia-Pacific Acute Lung Injury Market by Therapy
6.5.1. Key market trends
184.108.40.206. Brazil market size and forecast
6.5.4. LAMEA Acute Lung Injury Market by Therapy
Chapter: 7 COMPANY PROFILES
7.1. ALTOR BIOSCIENCE CORPORATION
7.1.1. Operating business segments
7.2. FIRSTSTRING RESEARCH, INC.
7.2.1. Operating business segments
7.3. GLAXOSMITHKLINE PLC
7.3.1. Operating business segments
7.4. FORSCHUNG UND ENTWICKLUNG GMBH
7.4.1. Operating business segments
7.5. COMMENCE BIO, INC.
7.5.1. Operating business segments
7.6. COMPLEGEN, INC.
7.6.1. Operating business segments
7.7. HISTOCELL S.L.
7.7.1. Operating business segments
7.8. STEMEDICA CELL TECHNOLOGIES, INC.
7.8.1. Operating business segments
7.9. WINDTREE THERAPEUTICS, INC.
7.9.1. Operating business segments
7.10. S-EVANS BIOSCIENCES, INC.
7.10.1. Operating business segments
With collective industry experience of about 200 years of its analysts and experts, Future Industry Insight (FII) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With FII’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
FII has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, FII’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.